InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
-0.74%
)
US TECH 100
18,122.00
(
-0.58%
)
Dow Jones
39,065.26
(
-1.53%
)
Brent Oil
81.31
(
-0.27%
)
Bitcoin
67,689.38
(
-2.05%
)
Post# of 644924
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Tuesday, 01/03/2023 9:47:57 AM

Tuesday, January 03, 2023 9:47:57 AM

Post# of 644924
ORTX $0.37 -MC $46 m-Cash $147 m --BLA filing imminent , they could get $100 million for their priority review voucher once drug is approved which expected later this year ...

Key Upcoming Clinical and Research Milestones ;

OTL-200 for MLD (U.S.): Conduct a pre-Biologics License Application (BLA) meeting with U.S. Food and Drug Administration (FDA) in the second half of 2022 in advance of a BLA submission timeline of late 2022 to early 2023.

OTL-203 for MPS-IH: Initiate a global registrational study in 2023.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up